Sign up to save your podcasts
Or
Share INC Research CEO reflects on Kendle acquisition
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
INC Research CEO reflects on Kendle acquisition
INC Research CEO James Ogle tells Outsourcing-pharma.com that the acquisition of fellow CRO Kendle was about building a presence in emerging trial hotspots and pharmaceutical markets.
View all episodes
By William Reed LtdINC Research CEO James Ogle tells Outsourcing-pharma.com that the acquisition of fellow CRO Kendle was about building a presence in emerging trial hotspots and pharmaceutical markets.